Menotropins are a type of medication used to help people who have trouble getting pregnant. They are made from the urine of women who have gone through menopause. This medication helps stimulate the ovaries to release eggs, which can improve the chances of conception. It's often used for infertility treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Menopur (Menotropins) for Infertility?
Menotropins, sold in the US as Menopur, is an injectable fertility medicine used during in vitro fertilization (IVF) and related treatments, where eggs are collected and fertilized in a lab. Its job is to help the ovaries develop several mature eggs in one cycle rather than the single egg of a natural cycle, which gives the lab more eggs and embryos to work with. In the US it is approved for women who ovulate and are going through assisted reproduction, after a fertility evaluation of both partners. It is not useful when the ovaries have stopped producing eggs (primary ovarian failure). Older menotropins brands, including Pergonal and Repronex, have been discontinued in the US, so Menopur is the product people encounter today.
Each month the pituitary gland, at the base of the brain, releases two hormones that drive egg development: follicle-stimulating hormone (FSH), which helps the fluid-filled sacs called follicles grow, and luteinizing hormone (LH), which supports the hormone production those follicles need. Menotropins supplies both, purified from the urine of postmenopausal women, whose bodies make these hormones in large amounts. A higher-than-natural dose encourages several follicles, each holding an egg, to grow at once. Menopur grows and matures follicles but does not make the ovaries release the eggs. When ultrasound scans and estradiol (an estrogen) blood tests show the follicles are ready, a separate trigger shot, usually human chorionic gonadotropin (hCG), completes egg maturation so the eggs can be retrieved. Large reviews comparing urine-derived hormones like menotropins with lab-made (recombinant) FSH have found similar live birth rates, so the choice often comes down to the clinic's protocol, cost and availability. Many clinics combine Menopur with a recombinant FSH product.
Menopur comes as a powder in small vials. Just before each injection it is mixed with the saline supplied, drawn into a syringe and injected under the skin of the belly. It is used right after mixing, and a dose may need more than one vial. The clinic teaches the mixing and injection steps before the cycle starts. Injections are usually given once a day, starting early in the menstrual cycle and typically lasting about one to two weeks (the label sets a limit of 20 days). The clinic sets the starting dose and adjusts it every few days according to how the follicles respond on ultrasound and blood tests, so doses often change partway through. Do not change the dose or schedule on your own. If a dose is missed, call the clinic for instructions rather than doubling the next one.
The most common effects are abdominal cramping, bloating or a sense of fullness, headache, and soreness, redness or swelling where the needle goes in. Some bloating and pelvic discomfort is expected as the ovaries enlarge, and it often peaks around egg retrieval. Nausea, breast tenderness and tiredness can also occur. The main serious risk is ovarian hyperstimulation syndrome (OHSS), in which overstimulated ovaries cause fluid to leak from blood vessels into the abdomen and sometimes the chest. In the IVF trial that supported approval, about 7 in 100 women developed some degree of OHSS, and severe cases are much less common. It can start after the injections end, typically peaks about a week after the trigger shot, and tends to be worse and last longer if pregnancy occurs. Call the clinic promptly about bloating that keeps increasing, nausea, or rapid weight gain. Seek emergency care for severe abdominal or pelvic pain, a rapidly swelling belly, trouble breathing, persistent vomiting, or passing very little urine. Sudden, severe pain on one side of the pelvis can mean an enlarged ovary has twisted (ovarian torsion), which cuts off its blood supply and needs emergency treatment to save the ovary.
Menopur is not used during pregnancy, so a pregnancy test is done before treatment. It is also not used in people with uncontrolled thyroid, adrenal or pituitary disease, tumors of the pituitary gland or hypothalamus, hormone-sensitive tumors of the reproductive organs, unexplained vaginal bleeding, or an ovarian cyst or enlargement that is not explained by polycystic ovary syndrome (PCOS). Fertility hormones can raise the risk of blood clots in veins or arteries, both with and without OHSS. Tell the care team about any personal or family history of blood clots, a known clotting disorder, or severe obesity, since these change how the risks and benefits are weighed. While the ovaries are enlarged, the clinic may advise avoiding intercourse because an ovarian cyst could rupture and bleed. Stimulating several eggs raises the chance of twins or more, especially when more than one embryo is transferred; in the Menopur IVF trial, about a third of pregnancies were multiple. Multiple pregnancy carries higher health risks for both the pregnant person and the babies, so it is worth discussing how many embryos to transfer. Ectopic pregnancy (one outside the uterus) and miscarriage are more common after fertility treatment, largely because of the underlying causes of infertility, so early blood tests and ultrasound confirm where a pregnancy is. No formal drug interaction studies have been done. Share a full list of medicines and supplements with the clinic. It is not known whether menotropins passes into breast milk, so discuss breastfeeding before starting.
A Menopur cycle is time-intensive. Expect frequent clinic visits for vaginal ultrasounds and blood tests, often every few days and sometimes daily near the end, because the dose and the timing of the trigger shot depend on the results. If the ovaries respond too strongly, the clinic may lower the dose, hold off on the trigger shot or change the plan for that cycle to lower the risk of OHSS. If the response is weak, the cycle may also be stopped and the plan changed for next time. Egg retrieval follows the trigger shot, timed by the clinic. Mild bloating and cramping for several days afterward is common, and the clinic will keep watching for OHSS over the following two weeks. Response varies a great deal between people and between cycles, depending mostly on age and ovarian reserve (the remaining supply of eggs), and one cycle does not guarantee a pregnancy. In the registration trial, about 1 in 4 women had an ongoing pregnancy after a single cycle.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Menopur (Menotropins), what you've noticed, or ask the community a question.